Canaccord downgraded Quipt Home Medical (QIPT) to Hold from Buy with a price target of $1.70, down from $4.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QIPT:
- Quipt Home Medical: Strategic Initiatives and Financial Resilience Amidst Revenue Challenges
- Quipt Home Medical Reports Q2 2025 Results Amid Revenue Challenges
- Is QIPT a Buy, Before Earnings?
- Quipt Home Medical to Release Q2 2025 Financial Results
- Strategic Growth and Expansion: Quipt Home Medical’s Path to Future Success